Danaher (DHR) Stock Forecast for 2025, 2026, 2027. Sell or Buy Prediction







Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency

April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency

What defines a successful crypto expert? The amount of money earned, the number of luxury cars and international real estate? The presence of…
Features of exchanging USDC ERC20 to Bank Transfer

March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer

You can use electronic exchange services if you need to exchange the digital asset USDC ERC20 to Bank Transfer. It is not recommended…
Why Stock Caps Matter When Building a Diversified Portfolio

February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio

Most investors who want to expand their investment options put their money in different asset types and industries across many areas in the…
Top 5 Coins for the Maximum Passive Income from Staking by 2024

February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024

Staking is one of the ways that is now being used as a secure and profitable way to earn money without doing anything…
Trading Stocks With AI: A Modern Approach

January 21, 2025 Trading Stocks With AI: A Modern Approach

The stock market can feel overwhelming, especially with its constant ups and downs. Trading stocks with AI is revolutionizing how investors analyze trends,…

Danaher (DHR) Stock Forecast for 2025, 2026, 2027. Sell or Buy?

Updated: May 22, 2025 (01:44)

Sector: Healthcare

The share price of Danaher Corp. (DHR) now

Latest session on the 21st of May for
Danaher Corp. is negative
Trading Volume: 5605095
Open: 195.74 /  High: 195.74 /  Low: 186.45
Current value: $186.81
What analysts predict: $247.05
52-week High/Low: $280.67 / $171
50-Day Moving Average: $198.26 — resistance level today
200-Day Moving Average: $234.16 — resistance level today

News Impact Analyzer

Full report
This Week
Na Impact: Na News: Na
Previous Week
Bullish Impact: 5 News: 1 (1/0/0)
Two Weeks Ago
Na Impact: Na News: 1
Three Weeks Ago
Bullish Impact: 3.13 News: 6 (3/2/1)

Analysts predictions

Full report
This Week
Neutral Opinions: 1
Previous Week
Neutral Opinions: Na
Two Weeks Ago
Neutral Opinions: Na
Three Weeks Ago
Neutral Opinions: Na

Analyzing the Most Important DHR news

Deutsche Bank Upgrades Johnson Controls on CEO-Led Margin Growth Potential

May 12, 2025
Trend: Bullish
Influence: 7
Deutsche Bank's upgrade highlights strong confidence in Johnson Controls' new CEO driving margin expansion, signaling optimistic growth prospects. This development positions JCI for potential upside, likely boosting investor sentiment and stock performance in the near term. While not directly tied to DHR, positive sector sentiment could provide ancillary benefits, especially in shared industrial or sustainability markets.

Danaher Maintains $0.32 Dividend Amid Modest Yield

May 06, 2025
Trend: Neutral
Influence: 3
The dividend announcement is routine and aligns with previous payouts, reflecting stability but no significant growth indicators. With a forward yield of 0.67%, this update is unlikely to impact the stock price dramatically. The low dividend yield and lack of surprises make this event a minor factor for near-term market influence.

Danaher Signals Confidence with Robust EPS Guidance for 2025

Apr 22, 2025
Trend: Bullish
Influence: 8
Danaher's strong Q1 results and optimistic 2025 EPS guidance highlight business resilience and growth potential, driving positive sentiment for investors. The momentum in key areas like bioprocessing and respiratory demand increases confidence, suggesting upward stock movement in the near term.

Historical and forecast chart of Danaher stock

The chart below shows the historical price of Danaher stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Danaher stock price can be found in the table below.

Long-term forecasts by years.

Danaher Corp. Analysts predictions review

Danaher Corporation's stock is expected to remain neutral in the near term, driven by a mix of stability and constrained growth potential. Key strengths include a diversified business model, strong cash flow generation, and a defensive position in recession-resilient industries. However, headwinds such as subdued end-market demand, cyclical softness in core segments like bioprocessing, and inflationary pressures could cap upside potential. While the company’s commitment to strategic acquisitions supports long-term growth, near-term performance may remain tempered due to cautious management guidance and uncertain macroeconomic conditions.

Danaher: Consistent Growth with Low Volatility in a Capital-Intensive Market

Trend: Neutral
May 06, 2025

Danaher Corporation operates in a capital-intensive industry, which naturally limits its scalability compared to more asset-light business models. However, the predictability of its operational cash flows, stemming from its diversification across life sciences, diagnostics, and environmental solutions, positions it as a stable, albeit lower-return, investment opportunity. The author's focus on this capital structure underscores the low-risk nature of the company's assets but also highlights the constrained upside potential for equity holders in high-growth environments.

Impact of Industry Trends and Competitive Dynamics

The company’s strong emphasis on innovation and strategic acquisitions provides a moat against competition, ensuring steady revenue growth. According to the analysis, while these strategies solidify its market position, the cash requirements for such moves could suppress margin expansion in the short term, impacting investors seeking high returns.

Danaher’s defensive positioning, supported by its presence in recession-resilient sectors like healthcare and environmental sustainability, has limited downside risk. This aligns with the author's characterization of the stock as a low-risk play, making it a practical holding for portfolios prioritizing stability over aggressive growth.

Macro factors, including potential inflationary pressures and rising interest rates, can increase operational costs and weigh on profitability. As noted, these external influences could moderately cap future earnings and reflect in the stock price's limited upside prospects.


Analyst: Mehmood P. Bakhsh
( Followers: 12
Articles: 2 )

Danaher: Limited Guidance Momentum Despite Strong Q1 Performance

Trend: Neutral
May 02, 2025

Danaher's first-quarter earnings exceeded expectations, highlighting the company's ability to maintain operational efficiency and manage costs effectively despite a challenging macroeconomic environment. However, the absence of a corresponding guidance upgrade raises questions about management's near-term growth outlook and the sustainability of current performance trends.

Macro Conditions and Product Demand

The potential headwinds from subdued end-market demand, particularly in key segments like life sciences and diagnostics, could create pressure on Danaher's revenue streams. This cautious demand outlook suggests that the broader economic constraints may weigh on near-term performance, limiting upside for the stock.

Cash flow trends and balance sheet strength continue to provide a strong foundation for Danaher's capital allocation strategies. Yet, the restrained guidance indicates management's preference for conservatism amid uncertain market conditions, which could temper investor sentiment in the months ahead.


Analyst: Miguel Daban
( Followers: 748
Articles: 59 )

Danaher: Strategic Resilience Amid Cyclical Challenges and Recovery Opportunities

Trend: Neutral
Apr 01, 2025

Danaher's robust track record of operational excellence continues to remain a defining feature of its business model, showcasing its ability to navigate macroeconomic uncertainties effectively. The author's insight underscores that while this strength provides stability, it is not sufficient to fully offset pressure stemming from a cyclically impacted business environment in the near term.

The slowdown in Danaher’s bioprocessing segment was highlighted as a key headwind, as it represents a significant portion of revenue generation. The author's perspective suggests that these challenges may temper the company’s growth trajectory, though recovery prospects in the broader healthcare sector offer some optimism.

Key Drivers of Stock Outlook

Another critical factor is Danaher’s commitment to strategic capital allocation and M&A activity, which has historically bolstered innovation and expanded its portfolio. The author points out that while these initiatives remain promising, investors may need to exercise caution given the cyclical softness in core markets.

Finally, the article builds on the expectation of tempered near-term earnings performance, framed by ongoing macroeconomic uncertainty and secular trends. This cautious outlook aligns with the author's hold rating, reflecting both the challenges and opportunities inherent in Danaher's current operating environment.


Analyst: Zen Analyst
( Followers: 7788
Articles: 324 )
Mar 31, 2025
Danaher: Navigating Short-Term Challenges Amid Promising Long-Term Opportunities
Trend: Neutral

Danaher Corporation’s stock faces short-term headwinds due to global economic uncertainties and macroeconomic pressures impacting sales growth in certain segments. Potential tightening of consumer and industrial spending could challenge near-term revenue momentum. However, the author emphasizes the company’s robust portfolio of innovative healthcare and life sciences solutions, which ensures long-term stability and competitiveness in high-growth markets.

Long-Term Strategic Positioning

The valuation remains attractive for investors, with P/E ratios trailing historical benchmarks, indicating potential upside as market sentiment stabilizes. Furthermore, Danaher’s focused approach to operational efficiency and strategic acquisitions positions it well for sustainable growth despite current challenges. Overall, while near-term performance may face volatility, the company’s long-term fundamentals remain sound and promising for patient investors.

Analyst: ABI Invest
( Followers: 93
Articles: 28 )
Mar 22, 2025
Danaher: Undervalued Opportunity Amidst Multi-Year Lows
Trend: Bullish

Danaher's recent stock performance reflects a confluence of factors, most notably the challenging macroeconomic conditions impacting the broader healthcare and life sciences sectors. The decline in valuation to nearly a 4-year low has created an attractive price point for long-term investors, especially given the company's strong fundamentals and historical resilience.

Key Drivers Influencing Danaher’s Stock Performance

The company’s robust balance sheet and consistent operating cash flow demonstrate its stability, which positions it well to navigate market uncertainties. The author emphasizes that these financial strengths not only mitigate downside risk but also provide flexibility for reinvestment and M&A opportunities.

However, softness in core end markets, particularly biopharma and diagnostics, is currently weighing on top-line growth. This sector-specific weakness is likely to persist in the short term, tempering immediate expectations for a significant recovery in revenue growth.

Danaher's track record of disciplined execution and innovation remains a critical competitive advantage. With management's strategic focus on higher-margin and high-growth segments, the company could reaccelerate growth as these markets stabilize in the medium to long term.

Valuation remains a compelling factor, as the stock's current multiple indicates significant upside potential compared to its historical range. The author underlines this as a key reason for the stock's attractiveness as a value play for patient investors.

Analyst: Hoya Capital
( Followers: 35459
Articles: 3436 )
Jan 16, 2025
Danaher: Navigating Strategic Shifts in a Pivotal Year
Trend: Neutral

Danaher's current transition phase underscores two primary operational shifts that are key to its near-term performance. One factor is the company's ongoing portfolio realignment, including the spin-offs and acquisitions aimed at optimizing its business focus on life sciences and diagnostics. The strategic targeting of high-growth healthcare sectors amplifies its long-term positioning but introduces short-term financial turbulence, impacting the stock's valuation trajectory.

Analyzing Near-Term Catalysts and Risks

The second factor identified is margin compression within core business segments. Heightened post-pandemic supply chain costs, paired with inflationary pressures, strain operating efficiency, creating uncertainty for earnings in upcoming quarters. Lastly, specific macroeconomic headwinds, including currency fluctuations and slowing demand in global markets, may further dampen near-term growth, warranting cautious optimism among investors.

Analyst: Miguel Daban
( Followers: 683
Articles: 44 )
Jan 15, 2025
Danaher Corporation: Evaluating Moat Resilience Amid Valuation Concerns
Trend: Bearish

Danaher Corporation's competitive edge, often referred to as its 'moat,' faces scrutiny due to potential erosion in its pricing power and operational efficiency. The author suggests that a shift in macroeconomic conditions, compounded by a possible slowdown in core business segments, challenges Danaher's ability to sustain its historical growth trajectory. This could signal vulnerability in the company's long-term profitability framework.

The Role of Valuation in Investor Outlook

Concerns around overvaluation add pressure to the stock's near-term outlook. According to the analysis, Danaher's current price-to-earnings ratio appears stretched when compared to sector peers, suggesting limited upside for investors unless earnings growth materially surprises to the upside. The valuation disconnect could make the stock susceptible to corrections.

Furthermore, shifting investor sentiment regarding defensive growth stocks appears to weigh on Danaher. If macroeconomic challenges persist, investors may opt for more attractively valued opportunities, exacerbating potential near-term headwinds for the stock.

Analyst: Daniel Schönberger
( Followers: 12723
Articles: 795 )
Jan 06, 2025
Danaher: Assessing Growth Potential Amid Strong Fundamentals
Trend: Bullish

Danaher Corporation's competitive advantage lies in its well-established wide economic moat, driven by a diverse portfolio of market-leading products and services. This strong positioning allows it to maintain pricing power and customer loyalty, both key factors in sustaining above-average profitability. The author's recognition of this moat highlights Danaher's resilience and potential for sustained revenue growth.

The company's recent strategic acquisitions have further enhanced its growth trajectory by expanding its presence in high-demand markets such as life sciences and diagnostics. These acquisitions are expected to generate both synergies and incremental revenue streams, solidifying Danaher's long-term growth thesis despite short-term integration costs, as noted by the author.

Long-Term Growth Versus Near-Term Challenges

Macroeconomic headwinds, including potential interest rate hikes and slowing global economic growth, pose challenges for Danaher in the near term. However, these are largely mitigated by its robust balance sheet and ample free cash flow, which ensure financial flexibility to navigate turbulence effectively. The author's emphasis on these risks versus Danaher's strengths underscores a balanced perspective.

The company's operational efficiency, bolstered by the implementation of the Danaher Business System (DBS), renders it more adaptable to changing market conditions. The systematic focus on continuous improvement and cost optimization enhances margin retention, a factor likely to support shareholder value even during periods of market volatility.

Analyst: Leo Nelissen
( Followers: 39333
Articles: 3175 )
Dec 10, 2024
Danaher: Positioned for Sustainable Growth Amid Sector Tailwinds
Trend: Bullish

Danaher's robust operational model, supported by its diversification across healthcare, life sciences, and diagnostics, underscores its resilience. The company's exposure to high-growth markets provides a defensive posture with upside potential, especially as macroeconomic uncertainties weigh on less diversified peers.

The ongoing integration of recent acquisitions enhances Danaher's market dominance and provides synergies that could bolster earnings in the near term. The author's analysis suggests a meticulous focus on high-ROI segments, ensuring shareholder value creation remains a priority.

Valuation and Growth Catalysts

Despite some pressure from rising input costs, Danaher's operational efficiencies and pricing power have shielded margins effectively. The relevance of its products in essential industries positions it well to navigate inflationary trends with relatively limited impact on profitability.

Technological advancements and innovation within its core segments, alongside increased R&D allocation, point to sustained long-term growth. Such efforts not only solidify its competitive edge but also align the company with future healthcare and science trends, driving recurring revenue streams.

Analyst: Daniel Mellado
( Followers: 63
Articles: 15 )
Jan 01, 1970
Reevaluating Danaher Corporation: Short-Term Factors Influencing Stock Performance
Trend: Neutral

Danaher Corporation’s performance hinges significantly on its ongoing business realignment efforts. Recent divestitures and acquisitions reflect a strategic pivot, aimed at refocusing on higher-margin segments, but this transition may introduce short-term volatility in earnings as integration costs surface.

Key Drivers Impacting DHR’s Near-Term Valuation

The company’s robust presence in the life sciences sector provides resilience through recurring revenue streams. However, macroeconomic headwinds like rising interest rates and tightening credit conditions may weigh on demand for capital-intensive equipment, potentially limiting upside momentum.

Operational efficiency initiatives, including cost controls, are positioned to mitigate margin pressures amid inflationary concerns. According to the author, these moves could enhance predictability in earnings over time but may not yield immediate margin expansion in upcoming quarters.

Investors should also monitor DHR’s pricing strategies in key markets. Despite competitive pressures, the company’s pricing power in its niche segments suggests room to defend profit margins, particularly as supply chain constraints continue to ease globally.

Analyst:
( Followers:
Articles: )

Comprehensive Analysis of Danaher (DHR) Stock Market Performance


Our multifaceted analysis of Danaher's stock market is grounded in the company's key news stories, insights from reputable analysts, as well as mathematical and technical evaluations. Taking into account assessments from each of these aspects in real-time helps us address the most crucial questions for investors in the most objective way possible:

  • When should I take profit in Danaher stock?
  • When should I record a loss on Danaher stock?
  • What are analysts' forecasts for Danaher stock?
  • What is the future of Danaher stock?

We forecast Danaher stock performance using neural networks based on historical data on Danaher stocks.

Danaher Corporation develops, manufactures and markets professional, medical, industrial and commercial products and services. The company operates in three segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of the body, including genes, proteins, metabolites and cells, in order to understand the causes of diseases, identify new therapies and test new drugs remedies and vaccines; Diagnostic business, which offers analytical instruments, reagents, consumables, software and services; and Environmental and Application Solutions, which include a variety of activities, including water quality assessment and product identification. Danaher has facilities for research and development, manufacturing, sales, distribution, service and administrative centers in more than 60 countries.

Danaher Corp. News influencing stock rates

As of now, Panda has combed through 8 news items directly related to DHR from the last 30 days. Out of these, 4 clearly showcase a bullish trend, while 1 display bearish tendencies, and 3 events are neutral.

The strength of the bullish trend outpaces the bearish sentiments by 4 times, indicating that the news backdrop is positively influencing the company’s stock price in the current outlook.

The news analyzed fell within the period from Apr 21, 2025, to May 12, 2025.

βeta
Apr 22, 2025

Danaher Q1 Beat Fails to Spark Enthusiasm as FY Guidance Sticks to Expectations

Trend: Neutral
Influence: 5
Despite beating Q1 earnings and revenue expectations, Danaher's full-year guidance matching consensus suggests limited upside potential. This neutral trend reflects the market's moderate reaction, with minimal enthusiasm for future growth. The influence level is mid-range, as better-than-expected results alone won't significantly impact the stock unless accompanied by upward FY guidance revisions or catalysts.
Apr 22, 2025

Danaher Exceeds Q1 Expectations, Provides FY25 & Q2 Guidance

Trend: Neutral
Influence: 6
Danaher posting better-than-expected Q1 earnings and offering forward-looking guidance reflects stable performance but lacks any dramatic positive catalysts. The news maintains investor confidence without signaling a sharp stock price movement. The influence is moderate, as future outlook clarifies direction but doesn't ignite significant bullish or bearish reactions in the immediate term.
Apr 22, 2025

Danaher Surpasses Q1 Expectations, Eyes Strong FY25 EPS & Q2 Forecast

Trend: Bullish
Influence: 8
Danaher's ability to exceed Q1 estimates combined with a promising FY25 EPS and Q2 outlook reflects strong operational execution and future optimism. This is likely to spur investor confidence, potentially driving the stock price higher in the near term. However, macroeconomic factors and industry-wide headwinds could moderate the impact.
Apr 22, 2025

Danaher Exceeds Q1 Expectations with Strong EPS and Revenue Beat

Trend: Bullish
Influence: 8
Danaher's better-than-expected EPS and revenue performance highlight strong operational efficiency, despite a slight YoY revenue decline. The company's robust cash flow further supports its financial stability. Such positive surprises generally boost investor confidence, likely driving the stock price higher in the short term. Consequently, the influence on the stock is significant, warranting a high bullish trend rating.
Apr 21, 2025

Danaher Faces Q1 2025 Earnings Challenge with Expected Decline in EPS and Revenue

Trend: Bearish
Influence: 7
The projected 14.6% EPS and 3.6% revenue decline signal weaker performance, which could negatively impact investor sentiment. As a reputable player, Danaher might struggle in the short term, especially under macroeconomic pressures. These indicators are strong enough to influence stock price movement downward unless positive surprises emerge during the earnings release.
Apr 16, 2025

Sartorius Q1 Surge: Boosting U.S. Life Sciences Stocks Pre-market

Trend: Bullish
Influence: 7
Sartorius' strong Q1 2025 results indicate robust sector performance, uplifting U.S. peers like DHR. Positive investor sentiment can drive DHR’s stock upward, given its alignment with Sartorius in the life sciences market. The level of influence is moderate-to-high due to sector-wide impact and the ripple effect on related companies' stock performance.
Apr 10, 2025

Barclays Downgrades CRO Leaders Amid Pharma Tariff Concerns

Trend: Neutral
Influence: 5
The downgrade reflects uncertainty around potential pharma tariffs, which could impact IQVIA, ICON, and Fortrea. However, DHR is not directly mentioned, suggesting a minimal effect on its stock price. The medium-level influence stems from broader biopharma market adjustments, which may evolve, indirectly affecting DHR in the future without clear immediate pressure.
Apr 05, 2025

Major Deals This Week: $9B Colonial Pipeline Acquisition and Strategic Moves

Trend: Neutral
Influence: 3
The post does not mention DHR directly or provide details affecting its operations. The highlighted deals, like Brookfield's acquisition, emphasize broader M&A activity trends, but have minimal direct impact on DHR's stock price. Consequently, the influence on DHR remains low (3), and its stock is unlikely to be significantly affected in the near term.
Mar 21, 2025

Goldman Sachs Sees Opportunity in Danaher, Upgrades to Buy

Trend: Bullish
Influence: 8
The upgrade by Goldman Sachs, a respected financial institution, signals strong confidence in Danaher’s growth potential. With a $260 target, this recommendation creates positive uptrend sentiment among investors, likely driving near-term stock price appreciation. The timing and trusted source amplify its influence significantly.
Mar 14, 2025

Danaher Upgraded: Stifel Sees Growth from Cost Savings Initiatives

Trend: Bullish
Influence: 7
The upgrade to 'Buy' and optimism about cost-saving measures boosting growth indicate a positive outlook for Danaher. Despite an underwhelming 2025 guidance, the market's response, with a 2% rise in stock value, reflects investor confidence. This news has significant potential to drive further stock momentum in the short-to-medium term.

Trending Themes in the Healthcare Sector

Danaher daily forecast for a month

Date Target Pes. Opt. Vol., %
May 23 186.96 185.80 187.48 0.91
May 24 186.38 185.15 187.24 1.13
May 25 184.57 183.10 185.68 1.41
May 26 183.70 182.95 184.84 1.03
May 27 184.57 183.24 186.01 1.51
May 28 184.03 182.80 185.14 1.28
May 29 184.12 183.44 185.60 1.17
May 30 184.11 182.95 185.43 1.36
May 31 183.09 181.67 184.32 1.46
Jun 01 182.80 182.36 183.95 0.87
Jun 02 181.21 180.30 182.30 1.11
Jun 03 182.68 181.95 183.35 0.77
Jun 04 182.93 181.56 183.98 1.33
Jun 05 182.95 182.40 183.98 0.86
Jun 06 182.33 181.69 183.52 1.00
Jun 07 181.91 181.40 183.18 0.98
Jun 08 181.29 180.15 182.31 1.20
Jun 09 181.60 180.96 182.38 0.78
Jun 10 181.75 180.33 182.98 1.47
Jun 11 181.33 180.02 181.76 0.97
Jun 12 181.80 180.73 182.73 1.11
Jun 13 182.27 181.18 183.26 1.15
Jun 14 183.91 183.12 185.05 1.05
Jun 15 183.91 182.92 185.38 1.35
Jun 16 184.96 183.92 185.85 1.05
Jun 17 186.29 185.44 187.13 0.91
Jun 18 185.10 184.29 186.47 1.19
Jun 19 185.54 184.97 186.14 0.63
Jun 20 186.27 185.04 187.59 1.38
Jun 21 185.73 185.19 187.18 1.07

Danaher Daily Price Targets


Danaher Stock Forecast 05-23-2025.

Forecast target price for 05-23-2025: $186.96.
Positive dynamics for Danaher shares will prevail with possible volatility of 0.897%.
Pessimistic target level: 185.80
Optimistic target level: 187.48

Danaher Stock Forecast 05-24-2025.

Forecast target price for 05-24-2025: $186.38.
Negative dynamics for Danaher shares will prevail with possible volatility of 1.115%.
Pessimistic target level: 185.15
Optimistic target level: 187.24

Danaher Stock Forecast 05-25-2025.

Forecast target price for 05-25-2025: $184.57.
Negative dynamics for Danaher shares will prevail with possible volatility of 1.392%.
Pessimistic target level: 183.10
Optimistic target level: 185.68

Danaher Stock Forecast 05-26-2025.

Forecast target price for 05-26-2025: $183.70.
Negative dynamics for Danaher shares will prevail with possible volatility of 1.024%.
Pessimistic target level: 182.95
Optimistic target level: 184.84

Danaher Stock Forecast 05-27-2025.

Forecast target price for 05-27-2025: $184.57.
Positive dynamics for Danaher shares will prevail with possible volatility of 1.489%.
Pessimistic target level: 183.24
Optimistic target level: 186.01

Danaher Stock Forecast 05-28-2025.

Forecast target price for 05-28-2025: $184.03.
Negative dynamics for Danaher shares will prevail with possible volatility of 1.262%.
Pessimistic target level: 182.80
Optimistic target level: 185.14

DHR (DHR) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jun. 204.07 197.36 211.79 6.81
Jul. 204.36 200.93 212.51 5.45
Aug. 207.36 199.96 213.17 6.20
Sep. 199.23 191.14 202.72 5.71
Oct. 192.40 189.03 195.77 3.44
Nov. 189.98 185.45 192.77 3.79
Dec. 184.39 174.45 187.10 6.76

Danaher forecast for this year


Danaher Stock Prediction for Jun 2025

An uptrend is forecast for this month with an optimal target price of $204.072. Pessimistic: $197.36. Optimistic: $211.79


Danaher Stock Prediction for Jul 2025

An uptrend is forecast for this month with an optimal target price of $204.358. Pessimistic: $200.93. Optimistic: $212.51


Danaher Stock Prediction for Aug 2025

An uptrend is forecast for this month with an optimal target price of $207.362. Pessimistic: $199.96. Optimistic: $213.17


Danaher Stock Prediction for Sep 2025

An downtrend is forecast for this month with an optimal target price of $199.233. Pessimistic: $191.14. Optimistic: $202.72


Danaher Stock Prediction for Oct 2025

An downtrend is forecast for this month with an optimal target price of $192.4. Pessimistic: $189.03. Optimistic: $195.77


Danaher Stock Prediction for Nov 2025

An downtrend is forecast for this month with an optimal target price of $189.975. Pessimistic: $185.45. Optimistic: $192.77


Danaher Stock Prediction for Dec 2025

An downtrend is forecast for this month with an optimal target price of $184.39. Pessimistic: $174.45. Optimistic: $187.10



Danaher (DHR) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 190.72 181.64 194.19 6.46
Feb 187.64 180.29 193.29 6.73
Mar 188.30 179.34 191.07 6.14
Apr 193.57 190.05 198.86 4.43
May 191.54 185.91 197.17 5.71
Jun 193.95 187.98 196.81 4.48
Jul 189.47 181.65 199.16 8.79
Aug 195.04 185.21 202.96 8.74
Sep 193.13 182.45 197.32 7.54
Oct 206.65 197.83 216.06 8.44
Nov 210.27 198.79 216.75 8.28
Dec 205.71 202.68 211.03 3.96

Danaher (DHR) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 203.40 196.14 209.38 6.32
Feb 200.41 189.47 205.88 7.97
Mar 205.04 198.30 211.64 6.31
Apr 196.29 185.29 205.49 9.83
May 205.49 194.56 212.25 8.34
Jun 211.53 207.68 216.12 3.91
Jul 214.20 208.05 223.20 6.79
Aug 213.60 204.48 224.96 9.11
Sep 211.95 208.54 216.41 3.63
Oct 207.50 202.71 210.70 3.79
Nov 212.59 207.23 217.50 4.72
Dec 216.75 206.59 223.28 7.47

Danaher information and performance

Danaher Address

2200 PENNSYLVANIA AVE. N.W., SUITE 800W, WASHINGTON, DC, US

Market Capitalization: 140 350 046 000 $

Market capitalization of the Danaher Corp. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of DHR shares in the company outstanding by the market price of one share.

EBITDA: 7 464 000 000 $

EBITDA of Danaher is earnings before interest, income tax and depreciation of assets.

PE Ratio: 38.01

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 1.926

Price/earnings to growth

DPS: 1.13

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: 0.0065

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 5.16

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.09
Quarterly Revenue Growth YOY: -0.009
Trailing PE: 38.01

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 25.97

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 6.5

Enterprise Value (EV) /Revenue

EV To EBITDA: 21.67

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 715670000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Danaher (DHR) stock dividend

Danaher last paid dividends on 06/27/2025. The next scheduled payment will be on 07/25/2025. The amount of dividends is $1.13 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.

FAQ (Frequently Asked Questions about Danaher Stock)

Should I Buy Danaher Shares in 2025 year?

The maximum forecasted share price for next year is $210.27, which is $23.46 higher than the current stock price. By investing in Danaher shares today for a one-year period, you could achieve a profit of 12.56%. With an investment horizon of up to two years, the target share price is $216.75. resulting in a profit of 16.03% ($29.94 per share).

Does Danaher pay dividends?

No, it does not

Which economic sector do Danaher's shares belong to?

Danaher's shares belong to the "Healthcare" sector of economic.

Which other securities belong to the same sector as Danaher's shares?

You can view all the stocks that are part of the same sector as Danaher's shares in the Healthcare section.


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.